动脉瘤性蛛网膜下腔出血后急性肾损伤及其对患者结局的影响:一项探索性分析
高血压病史和肾毒性药物数量是AKI独立预测因素;AKI是死亡的独立预测因素,但与12周功能结局不良无关。未缓解的肾功能障碍是死亡最强独立预测因素。
要点
- 高血压病史和肾毒性药物数量是AKI独立预测因素。
- AKI独立预测死亡,未缓解肾功能障碍预测死亡最强。
核心结论
- AKI是aSAH后常见并发症,高血压病史和使用肾毒性药物者风险更高,AKI与死亡风险增加相关。
研究设计与样本
- 对CONSCIOUS-1试验(NCT00111085)数据行事后分析,共纳入413例aSAH患者,AKI按KDIGO指南定义。
主要发现
- 多变量分析示高血压病史(p < 0.001)和肾毒性药物数量(p = 0.029)为AKI独立预测因素。
- AKI为死亡的独立预测因素(p = 0.028),但不是功能结局不良的独立预测因素(p = 0.21)。
- 未缓解的肾功能障碍是该队列死亡最强独立预测因素(p < 0.001)。
关键数值与推荐
- AKI定义采用KDIGO指南。
- 功能结局不良定义为12周改良Rankin量表评分大于2。
临床怎么用
- 对aSAH患者应关注高血压病史及肾毒性药物使用,监测并防治AKI,肾功能未缓解者死亡风险高。
局限性
- 本文为探索性事后分析,原始摘要未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute kidney injury (AKI) is associated with death in critically ill patients, but this complication has not been well characterized after aneurysmal subarachnoid hemorrhage (aSAH). The purpose of this study was to determine the incidence of AKI after aSAH and to identify risk factors for renal dysfunction. Secondary objectives were to examine what effect AKI has on patient mortality and functional outcome at 12 weeks post-aSAH. METHODS: The authors performed a post hoc analysis of the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) trial data set (clinical trial registration no.: NCT00111085, https://clinicaltrials.gov). The primary outcome of interest was the development of AKI, which was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Secondary outcomes of interest were death and a modified Rankin Scale score greater than 2 at 12 weeks post-aSAH. Propensity score matching was used to assess for a significant treatment effect related to clazosentan administration and AKI. Univariate analysis, locally weighted scatterplot smoothing (LOWESS) curves, and stepwise logistic regression models were used to evaluate for associations between baseline or disease-related characteristics and study outcomes. RESULTS: One hundred fifty-six (38%) of the 413 patients enrolled in the CONSCIOUS-1 trial developed AKI during their ICU stay. A history of hypertension (p < 0.001) and the number of nephrotoxic medications administered (p = 0.029) were independent predictors of AKI on multivariate analysis. AKI was an independent predictor of death (p = 0.028) but not a poor functional outcome (p = 0.21) on multivariate testing. Unresolved renal dysfunction was the strongest independent predictor of death in this cohort (p < 0.001). CONCLUSIONS: AKI is a common complication following aSAH. Patients with premorbid hypertension and those treated with nephrotoxic medications may be at greater risk for renal dysfunction. AKI appears to confer an increased probability of death after aSAH.
引用
- Eagles ME, Powell MF, Ayling OGS, et al. Acute kidney injury after aneurysmal subarachnoid hemorrhage and its effect on patient outcome: an exploratory analysis. J Neurosurg. 2019. PMID: 31299650. doi:10.3171/2019.4.JNS19103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。